BRIEF-Liquidia Announces Global Settlement Resolving All Pending Litigation With United Therapeutics, Ensuring Continued Commercialization Of Yutrepia In Pah
Reuters2026/10/13 21:50Liquidia Corporation LQDA.O:
LIQUIDIA ANNOUNCES GLOBAL SETTLEMENT RESOLVING ALL PENDING LITIGATION WITH UNITED THERAPEUTICS, ENSURING CONTINUED COMMERCIALIZATION OF YUTREPIA IN PAH
LIQUIDIA CORPORATION - SETTLEMENT FULLY RESOLVES SIX ONGOING LAWSUITS BETWEEN LIQUIDIA AND UNITED THERAPEUTICS
LIQUIDIA CORPORATION - TO PAY NET $380.70 MILLION IN INSTALLMENTS IN 2026 AND 2027
LIQUIDIA CORPORATION - TO PAY $175 MILLION TO UNITED THERAPEUTICS WITHIN 30 BUSINESS DAYS
LIQUIDIA CORPORATION - TERMINATES PROMOTIONAL AGREEMENT FOR TREPROSTINIL INJECTION
LIQUIDIA CORPORATION - YUTREPIA REMAINS AVAILABLE TO PAH PATIENTS WITHOUT DISRUPTION
LIQUIDIA CORPORATION - REMOVES PH-ILD INDICATION FROM YUTREPIA LABEL AND CEASES PROMOTION
Source text: ID:nGNX9cxvQg
Further company coverage: LQDA.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Exclusive report - Boeing memo says sales chief McMullen will retire
Robo.ai Announces Extraordinary General Meeting
Intel Corp. Stock Falls 5.8%, Underperforms Peers
Circle details USDC revenue split, says $819 million went to partners and costs in H1 2026
Crypto prices
More
